Literature DB >> 9305925

Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases.

M S Rosendahl1, S C Ko, D L Long, M T Brewer, B Rosenzweig, E Hedl, L Anderson, S M Pyle, J Moreland, M A Meyers, T Kohno, D Lyons, H S Lichenstein.   

Abstract

Tumor necrosis factor-alpha (TNF) is initially expressed as a 26-kDa membrane-bound precusor protein (pro-TNF) that is shed proteolytically from the cell surface, releasing soluble 17-kDa TNF. We have identified human ADAM 10 (HuAD10) from THP-1 membrane extracts as a metalloprotease that specifically clips a peptide substrate spanning the authentic cleavage site between Ala76 and Val77 in pro-TNF. To confirm that HuAD10 has TNF processing activity, we cloned, expressed, and purified an active, truncated form of HuAD10. Characterization of recombinant HuAD10 (rHuAD10) suggests that this enzyme has many of the properties (i.e. substrate specificity, metalloprotease activity, cellular location) expected for a physiologically relevant TNF-processing enzyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305925     DOI: 10.1074/jbc.272.39.24588

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.

Authors:  H Koike; S Tomioka; H Sorimachi; T C Saido; K Maruyama; A Okuyama; A Fujisawa-Sehara; S Ohno; K Suzuki; S Ishiura
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

2.  Alternative proteolytic processing of mouse mammary tumor virus superantigens.

Authors:  F Denis; N H Shoukry; M Delcourt; J Thibodeau; N Labrecque; H McGrath; J S Munzer; N G Seidah; R P Sékaly
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Cloning and characterization of ADAM28: evidence for autocatalytic pro-domain removal and for cell surface localization of mature ADAM28.

Authors:  L Howard; R A Maciewicz; C P Blobel
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

4.  Emphysema mediated by lung overexpression of ADAM10.

Authors:  Hiroki Saitoh; Philip L Leopold; Ben-Gary Harvey; Timothy P O'Connor; Stefan Worgall; Neil R Hackett; Ronald G Crystal
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

Review 5.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

6.  Variability in melanoma metalloproteinase expression profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  J Biomol Tech       Date:  2010-12

7.  Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region.

Authors:  Sven Lammich; Dominik Buell; Sonja Zilow; Ann-Katrin Ludwig; Brigitte Nuscher; Stefan F Lichtenthaler; Claudia Prinzen; Falk Fahrenholz; Christian Haass
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

8.  Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization.

Authors:  N G Seidah; S J Mowla; J Hamelin; A M Mamarbachi; S Benjannet; B B Touré; A Basak; J S Munzer; J Marcinkiewicz; M Zhong; J C Barale; C Lazure; R A Murphy; M Chrétien; M Marcinkiewicz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.

Authors:  Matthias Canault; Aurélie S Leroyer; Franck Peiretti; Guy Lesèche; Alain Tedgui; Bernadette Bonardo; Marie-Christine Alessi; Chantal M Boulanger; Gilles Nalbone
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

10.  The regulation of TACE catalytic function by its prodomain.

Authors:  Xiaoou Li; Yuan Yan; Wei Huang; Yuzhen Yang; Hongwei Wang; Liwen Chang
Journal:  Mol Biol Rep       Date:  2008-04-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.